Related Experiment Video

Updated: May 13, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

Amitotic Cell Division, Malignancy, and Resistance to Anticancer Agents: A Tribute to Drs. Walen and Rajaraman

Razmik Mirzayans1, David Murray1

  • 1Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.

Cancers
|September 14, 2024
PubMed

Insights

Polyploid giant cancer cells (PGCCs) can divide amitotically, producing daughter cells with stem cell-like properties that may drive tumor growth and therapy resistance. This commentary updates discoveries on PGCCs and amitotic cell division.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Genetics

Background:

  • Cell division, including mitosis, meiosis, and amitosis, is fundamental for life.
  • Amitosis, characterized by nuclear budding, occurs in abnormal, large cells like polyploid cells.
  • Polyploid giant cancer cells (PGCCs) are found in tumors and linked to treatment resistance.

Purpose of the Study:

  • To provide an update on discoveries concerning amitotic cell division in polyploid cells.
  • To highlight the role of polyploid giant cancer cells (PGCCs) in tumorigenesis and therapy resistance.
  • To honor the foundational work of Drs. Kirsten Walen and Rengaswami Rajaraman.

Main Methods:

  • Review of early 2000s research by Walen and Rajaraman on polyploid cell division.
  • Analysis of the properties of daughter cells produced via amitosis.
  • Examination of the contribution of PGCCs to cancer progression and treatment outcomes.

Main Results:

  • Polyploid human cells can undergo amitotic division, generating progeny.
  • A subset of these daughter cells exhibit rapid proliferation and stem cell-like characteristics.
  • PGCCs contribute significantly to tumor recurrence and resistance to cancer therapies.

Conclusions:

  • Amitotic cell division in polyploid cells, particularly PGCCs, represents a significant mechanism in cancer development and treatment failure.
  • Further research into PGCCs and their unique division processes is crucial for advancing cancer therapy.
  • The work of Walen and Rajaraman laid the groundwork for understanding these critical aspects of cancer biology.
Keywords:
amitotic cell divisiongenome chaosintratumor heterogeneityneosispolyploid giant cancer cellspolyploidytherapy resistance

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...